Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
TRIALS UPDATE: The Latest Alzheimer’s Clinical Trial News (2025.02)
The First FDA-Approved Alzheimer’s Blood Test: What You Need to Know
This Shingles Vaccine Could Cut Your Dementia Risk By 1/5
Is a Cellular ‘Stalled Engine’ Causing Alzheimer’s?
Stem Cells for Alzheimer’s? Neurologists Weigh In on Longeveron’s New Data
Everything You Wanted to Know About ARIA
Precision Prevention: The Latest on Alzheimer’s Vaccines
A Stem Cell Therapy for Parkinson’s Disease Heads to Phase 3 Trials
How Down Syndrome Research Is Helping Scientists Understand Alzheimer’s
EU Approves Leqembi: Regulators Flip from ‘No’ to ‘Yes’ on Alzheimer’s Drug
Alzheimer’s Drug Trials: Do Drug Companies Warn You About Your Genetic Risk?
Trojan Horse: Carrying Alzheimer’s Antibodies Into the Brain
It Takes Tau to Tangle: Is Faster Buildup Driving Women’s Alzheimer’s Risk?
In Trials: A Powerful Magnet for Zapping Alzheimer’s Away
States Propose Bills to Make Private Insurers Cover Approved Alzheimer’s Drugs, Diagnostics
Previous
7
8
9
Next
Page load link
Go to Top